125049-81-2

Upstream product

• 622-33-3 N-benzyloxyamine 
• 89969-26-6 (S)-3-(3-benzyloxycarbonyl-5-oxo-1,3-oxazolidin-4-yl)propionaldehyde 
• 1155-62-0 N-benzyloxycarbonyl-L-glutamic acid 
• 23632-67-9 (S)-3-[3-(benzyloxycarbonyl)-5-oxooxazolidin-4-yl]propanoic acid 
• 58456-26-1 (S)-4-<2'-(Chloroformyl)ethyl>-5-oxooxazolidin-3-carbonsaeure-benzylester 

Downstream Products

• 89969-28-8 δ-N-acetyl-δ-N-benzyloxy-L-ornithine 
• 125050-20-6 (S)-3-benzyloxycarbonylamino-1-benzyloxypiperidin-2-one 
• 89969-29-9 N⁵-acetyl-N⁵-(benzyloxy)-N²-(benzyloxycarbonyl)-L-ornithine 
• 52816-28-1 N⁵-Acetyl-N⁵-benzyloxy-L-ornithin 
• 125049-82-3 (R)-4-[3-(Benzyloxy-methyl-amino)-propyl]-5-oxo-oxazolidine-3-carboxylic acid benzyl ester 
• 125049-95-8 α-N-Cbz-δ-N-(Benzyloxy)-D-cycloornithine 

Relevant academic research and scientific papers

CONSTITUENTS OF MICROBIAL IRON CHELATORS. THE SYNTHESIS OF OPTICALLY ACTIVE DERIVATIVES OF δ-N-HYDROXY-L-ORNITHINE.

δ-N-Hydroxy-L-ornithine derivatives were synthesized from L-glutamic acid by reduction of the γ-acid chloride to the aldehyde, formation of the substituted oxime, and reductive acylation